Clinical trial
A Phase I Study of LY2523355 in Patients With Advanced Cancer
NCT01214629 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of LY2523355 in Patients With Advanced Cancer
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2007
- Completion date
- May 31, 2012
- Enrollment
- 54 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
advanced cancer, metastatic cancer